GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Board to Approve Q2 FY27 Financial Results

RESULTS ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 05 Nov 2026, 01:18 PM IST  ·  BSE ID: 6fbb1b52-ac0c-4357-a4de-5d1d2fd1e336
View Original BSE Filing (PDF)
💡
In Simple Terms
Kwality Pharmaceuticals is holding a board meeting on November 12, 2026, to approve its financial results for the quarter ending September 30, 2026.
🤖 AI Summary
  • Kwality Pharmaceuticals Board Meeting scheduled for Thursday, November 12, 2026, at 10:30 A.M.
  • Main agenda is to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 (Q2 FY27).
  • Trading Window for designated persons remains closed until 48 hours after financial results declaration on November 12, 2026.
  • The meeting will take place at the company's registered office in Village Nag Kalan, Amritsar, Punjab-143601.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any action based on this specific intimation.
👤
Who Is Affected
Designated persons, their immediate relatives, and other connected persons are affected by the trading window closure.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the board meeting for financial results approval and maintaining the trading window closure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Kwality Pharmaceuticals' Q2 FY27 Unaudited Financial Results release on November 12, 2026.
Any further announcements regarding board decisions from the November 12, 2026 meeting.
Details of the Standalone and Consolidated Financial Results for Q2 FY27.
LOW RISK This filing is a routine regulatory intimation of a board meeting to approve results, not indicating any direct new risks.
💡 Investor Takeaway
Kwality Pharmaceuticals Ltd. has scheduled a board meeting on November 12, 2026, to consider and approve its Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 (Q2 FY27). The trading window remains closed until 48 hours post results declaration.
❓ Frequently Asked Questions
When is the Kwality Pharmaceuticals Ltd board meeting scheduled?
The Board of Directors meeting for Kwality Pharmaceuticals Ltd is scheduled for Thursday, November 12, 2026, at 10:30 A.M.
What is the primary agenda for the Kwality Pharmaceuticals board meeting on November 12, 2026?
The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on 30th September, 2026 (Q2 FY27).
When will the trading window reopen for Kwality Pharmaceuticals Ltd?
The trading window for designated persons, their immediate relatives, and other connected persons shall remain closed till 48 hours after the declaration of Financial Results on November 12, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.